Our data suggest that IL-36γ could be a potential biomarker for viral infections in COPD, especially as IL-36 cytokines can be detected in nasal samples; therefore, patients can be noninvasively tested during these episodes. This evidence concerns the gene IL36G and viral infectious disease.